New
HealthMore in Health→
Does Expanding Clinical Trial Capacity Really Improve Healthcare Access?
Key Takeaways
- A Nature Medicine commentary published 25 September 2026 asks whether expanded clinical trial capacity translates into improved healthcare access.
- It notes that clinical trials are essential for patient access to biomedical innovation and that China's trial activity has grown rapidly over the past decade.
- The authors caution that this growth has been concentrated in top-tier institutions and requires careful management to improve equitable access.
- A figure accompanying the article is described as showing the structural concentration of clinical trial activity in China.
DE
DT Editorial Team··via nature.com